Sol-Gel Technologies Ltd. logo
Sol-Gel Technologies Ltd. SLGL
€ 64.44 2.12%

Geschäftsbericht 2025
hinzugefügt 25.04.2026

report update icon

Sol-Gel Technologies Ltd. Abschreibung & Amortisation 2011-2026 | SLGL

Abschreibung & Amortisation Jährlich Sol-Gel Technologies Ltd.

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - - - 880 K 946 K 887 K 762 K 471 K 359 K 300 K - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
946 K 300 K 658 K

Abschreibung & Amortisation anderer Aktien in der Pharmaeinzelhändler

Name Abschreibung & Amortisation Preis % 24h Marktkapitalisierung Land
AgeX Therapeutics AgeX Therapeutics
AGE
100 K - -10.17 % $ 12.2 K usaUSA
I-Mab I-Mab
IMAB
23.9 M - - $ 866 M chinaChina
Akero Therapeutics Akero Therapeutics
AKRO
18 K - - $ 3.67 B usaUSA
AlloVir AlloVir
ALVR
13 K - 4.14 % $ 49.1 M usaUSA
Cerus Corporation Cerus Corporation
CERS
1.43 M $ 2.72 33.99 % $ 518 M usaUSA
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
920 K $ 21.95 -2.23 % $ 3.64 B usaUSA
Athira Pharma Athira Pharma
ATHA
972 K - - $ 269 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
3.13 M - - $ 10.1 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
162 K - - $ 7.46 M israelIsrael
Atreca Atreca
BCEL
5.46 M - -11.76 % $ 5.79 M usaUSA
Berkeley Lights Berkeley Lights
BLI
9 M - -7.31 % $ 87 M usaUSA
Calithera Biosciences Calithera Biosciences
CALA
300 K - -10.95 % $ 876 K usaUSA
Advaxis Advaxis
ADXS
369 K - -9.65 % $ 45.9 M usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
681 K - - $ 3.45 B usaUSA
ChemoCentryx ChemoCentryx
CCXI
3.14 M - - $ 3.74 B usaUSA
Cardiff Oncology Cardiff Oncology
CRDF
364 K $ 1.71 -1.16 % $ 114 M usaUSA
Caladrius Biosciences Caladrius Biosciences
CLBS
174 K - -16.75 % $ 25.8 M usaUSA
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
66 K - - $ 231 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
58 K - 5.93 % $ 314 M canadaCanada
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
199 K - -2.5 % $ 5.88 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
744 K - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.51 M - - $ 26.5 M usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
2.1 M - - $ 2.18 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
105 K - 1.93 % $ 17.4 M usaUSA
Editas Medicine Editas Medicine
EDIT
5.28 M $ 2.9 -3.33 % $ 257 M usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
4.63 M - - $ 2.02 B usaUSA
Edesa Biotech Edesa Biotech
EDSA
186 K $ 17.59 -3.75 % $ 56.2 M usaUSA
Akouos Akouos
AKUS
2.49 M - 0.23 % $ 488 M usaUSA
Allakos Allakos
ALLK
6.14 M - - $ 28.6 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
24 K $ 2.93 -8.15 % $ 4.82 M israelIsrael
Eiger BioPharmaceuticals Eiger BioPharmaceuticals
EIGR
275 K - -9.21 % $ 2.55 M usaUSA
Eloxx Pharmaceuticals Eloxx Pharmaceuticals
ELOX
77 K - -5.68 % $ 8.28 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
122 K - -11.43 % $ 502 K usaUSA
Aptose Biosciences Aptose Biosciences
APTO
22 K - -45.71 % $ 1.2 M canadaCanada
Aptinyx Aptinyx
APTX
122 K - -39.0 % $ 4.57 M usaUSA
Aravive Aravive
ARAV
886 K - -13.39 % $ 1.45 M usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
487 K - 17.91 % $ 11.1 M usaUSA